Segal Lloyd Mitchell 4
4 · Repare Therapeutics Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-30+344,200→ 344,200 totalExercise: $12.42Exp: 2033-01-29→ Common Shares (344,200 underlying) - Award
Common Shares
2023-01-30+78,550→ 84,677 total
Holdings
- 94,466(indirect: See footnote)
Common Shares
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of January 30, 2024, January 30, 2025 and January 30, 2026, subject to Reporting Person continuing to provide service through each such date.
- [F2]Includes 398 shares and 729 shares acquired on August 13, 2021 and February 15, 2022, respectively, under the Issuer's employee stock purchase plan.
- [F3]These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.
- [F4]Twenty-five percent (25%) of the shares subject to the option shall vest on January 30, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.